Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial inner membrane proton conductance (MIMPC) is a physiological process characterized by the movement of protons from the intermembrane space back into the mitochondrial matrix, bypassing the ATP synthase (Source 1.1.2). This phenomenon, often referred to as mitochondrial proton leak or uncoupling, dissipates the electrochemical gradient (proton-motive force) and releases energy as heat instead of capturing it as ATP (Source 1.2.1). MIMPC is mediated by the intrinsic permeability of the lipid bilayer and specific transport proteins, most notably the uncoupling proteins (UCP1, UCP2, UCP3) and the adenine nucleotide translocator (ANT) (Source 1.1.2, 1.2.1). Pharmacological modulation of this conductance is a significant therapeutic strategy; increasing conductance (uncoupling) can stimulate metabolism to treat obesity, type 2 diabetes, and nonalcoholic fatty liver disease (NAFLD) (Source 1.3.5, 1.4.2). Additionally, mild uncoupling is thought to reduce the production of reactive oxygen species (ROS), providing potential neuroprotective and cardioprotective effects (Source 1.3.4, 1.5.2). However, the therapeutic use of uncouplers is limited by a narrow safety margin, as excessive conductance can lead to life-threatening hyperthermia and cellular energy failure (Source 1.2.1, 1.3.5).
Protonophore, Uncoupling protein activation, Mitochondrial uncoupling, Dissipation of proton-motive force
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial inner membrane proton conductance (MIMPC).